| Future directions in renal cell carcinoma: 2011 And beyond - Abstract - UroToday |
|
|
UroToday Emerging from a largely cytokine-based era, the last several years have witnessed a dramatic change in the therapeutic landscape of renal cancer. Molecularly targeted and antiangiogenic agents now form the backbone of most therapeutic strategies for |